Survey of infection in patients receiving antibody replacement treatment for immune deficiency
Background:0 Primary antibody deficiency disorders are a heterogeneous group of disorders, which are treated by regular infusions of immunoglobulin. Despite replacement treatment, patients remain susceptible to infection. Effective management of infections is necessary to prevent the complications o...
Saved in:
Published in | Journal of clinical pathology Vol. 55; no. 8; pp. 577 - 580 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group Ltd and Association of Clinical Pathologists
01.08.2002
BMJ BMJ Publishing Group Ltd BMJ Publishing Group LTD Copyright 2002 Journal of Clinical Pathology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background:0 Primary antibody deficiency disorders are a heterogeneous group of disorders, which are treated by regular infusions of immunoglobulin. Despite replacement treatment, patients remain susceptible to infection. Effective management of infections is necessary to prevent the complications of chronic infection. Aims: This retrospective survey of clinical practice examined the management of infections in patients who receive immunoglobulin replacement for immune deficiency. Methods: Patients who received immunoglobulin replacement treatment in Newcastle during the year 2000 were identified. Medical records were reviewed. Basic clinical information and details of immunoglobulin replacement treatment were recorded. Episodes of infection were defined by documented symptoms, signs, or investigation results, and by the prescription of an antibiotic course. Details of episodes of infection and antimicrobial treatment were recorded. Results: Thirty seven patients received immunoglobulin replacement during 2000. There were 101 episodes of infection. There was no correlation between the frequency of infection and the IgG trough value. Respiratory tract infections were most common (71 of 101). Where documented, 80% of infections were associated with clinical signs, 21% with pyrexia, and 64% with a raised C reactive protein value. Microbiological culture was performed in 30% of infections. Antimicrobial treatment was instituted along “best guess” lines in 99 of 101 episodes of infection. Conclusions: Management of respiratory tract infections represents the largest problem in antibody deficient patients. Greater use of microbiological culture might allow more effective prescription of antimicrobial treatment. The generation of treatment guidelines and improved communication with general practitioners could improve the management of all episodes of infection. |
---|---|
Bibliography: | Correspondence to:
Dr G Spickett, Department of Immunology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK;
gavin.spickett@nuth.northy.nhs.uk href:jclinpath-55-577.pdf PMID:12147649 ark:/67375/NVC-PC1WG1S3-0 local:0550577 istex:126534F7590CD698D135AA7A5A0FD04FA94920B9 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Correspondence to: Dr G Spickett, Department of Immunology, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK; gavin.spickett@nuth.northy.nhs.uk |
ISSN: | 0021-9746 1472-4146 |
DOI: | 10.1136/jcp.55.8.577 |